Qiagen (QGEN) Tops Q2 EPS by 5c; Raises Outlook

Qiagen (NYSE: QGEN) reported Q2 EPS of $0.51, $0.05 better than the analyst estimate of $0.46. Revenue for the quarter came in at $516 million versus the consensus estimate of $505.01 million.

GUIDANCE:

Qiagen sees FY2022 EPS of at least $2.30. Qiagen sees FY2022 revenue of at least $2.2 billion.

For earnings history and earnings-related data on Qiagen (QGEN) click here.

You May Also Be Interested In

• Morgan Stanley Upgrades QIAGEN NV (QIA:GR) (QGEN) to Overweight
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• Jefferies Reinstates Talen Energy (TLN) at Hold